
Dr. Khaled Hassan Attia Ghorab
Consultant Critical Care Medicine
Pulmonology
0 verified reviews
0
Recent Consultations
About Dr. Khaled Hassan Attia Ghorab
Dr. Khaled Hassan Attia Ghorab is a Consultant in Critical Care Medicine at Burjeel Medical City, Abu Dhabi. A graduate of Alexandria University's Faculty of Medicine, he holds a European Diploma in Intensive Care Medicine and is certified by the Arab Board of Anesthesia and Intensive Care Medicine.
With over 25 years of clinical experience, Dr. Ghorab has worked in major tertiary care hospitals across Saudi Arabia and the United Arab Emirates. His practice encompasses the full range of critical care conditions, with particular expertise in septic shock, acute respiratory failure, acute respiratory distress syndrome (ARDS), traumatic brain injury, and infectious disease management.
Dr. Ghorab is fluent in English and Arabic and maintains active membership in the Infectious Disease Society of America (IDSA), the European Society of Intensive Care Medicine (ESICM), and the British Society of Antimicrobial Chemotherapy (BSAC).
Conditions Treated by Dr. Khaled Hassan Attia Ghorab
- Septic shock
- Acute respiratory failure
- Acute respiratory distress syndrome (ARDS)
- Traumatic brain injury
- Infectious disease
Areas of Interest
- Critical Care and ICU
- Pulmonology
Qualifications
- Faculty of Medicine — Alexandria University
- European Diploma in Intensive Care Medicine —
Work Experience
- Consultant Critical Care Medicine, Burjeel Medical City, Abu Dhabi
- Critical Care Physician in major tertiary care hospitals in Saudi Arabia and the United Arab Emirates
Certifications (1)
Arab Board of Anesthesia and Intensive Care Medicine
Memberships (3)
- Infectious Disease Society of America (IDSA)
- European Society of Intensive Care Medicine (ESICM)
- British Society of Antimicrobial Chemotherapy (BSAC)
Research Papers & Publications (0)
Procedures
Frequently Asked Questions
Dr. Ghorab is a Consultant in Critical Care Medicine, specializing in the management of critically ill patients in intensive care units.
